Quantum Biopharma Ltd (HUGE) Return on Investment ROI from the third quarter of 2025 to third quarter of 2024 and for the year 2025, average high and low, overall ranking from Sep 30 2025 to 0 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Quantum Biopharma Ltd   (NASDAQ: HUGE)


Quantum Biopharma Ltd's ROI from its third quarter of 2025 to the third quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Quantum Biopharma Ltd's ROI in the third quarter of 2025?
Quantum Biopharma Ltd recorded a cumulative net loss of $-37 million during 12 months ending in the third quarter of 2025, resulting in a negative return on investment (ROI) of -359.59%.

Within the Healthcare sector 471 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2025 from 4232 to 4590.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 0
III. Quarter
Y / Y Investment Change TTM -12.29 % -9.7 % 2.1 % -11.36 % -15.35 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 7 10 12 13 10
Return On Investment (TTM) -359.59 % -325.52 % -240.53 % -195.13 % -230.4 %
HUGE's Overall Ranking # 4590 # 4232 # 0 # #
Seq. Investment Change TTM -7.67 % -10.47 % 3.92 % 2.11 % -4.94 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -37 -37 -30 -24 -27

HUGE Company Profile >> Back to HUGE Roi Comparisons >> See Annual HUGE Return On Investment



Return On Investment HUGE's Ranking
Within: No.
Industry # 192
Sector # 472
Overall # 4590

Return On Investment Statistics
High Average Low
-42.08 %
-86.94 %
-138.68 %
(Sep 30 2025)   (Dec 31 2023)







Financial Statements
Quantum Biopharma Ltd's III. Quarter Investments $ 7 Millions HUGE's Balance sheet
Quantum Biopharma Ltd's III. Quarter Income $ -5 Millions Quarterly HUGE's Income Statement
HUGE's Income by Division See HUGE's Income by Division


HUGE Annual Return On Investment (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020
Total Investments in Millions 6 10 13 31 54
Y / Y Investment Growth -39.23 % -19.13 % -57.79 % -43.64 % 49.45 %
Net Income in Millions -14 -18 -24 -35 -32
Y / Y Net Income Growth - - - - -
Annual Return On Investment -223.85 % -171.47 % -182.87 % -115.39 % -58.6 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
HUGE's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for HUGE's Competitors
Subscribers only: Roi for Quantum Biopharma Ltd's Suppliers
Subscribers only: Return On Investment for HUGE's Customers

Other Ratios
HUGE's Roa HUGE's Inventory Turnover Ratio HUGE's Growth Rates HUGE's Dividend Statistics
HUGE's Profitability Ratios HUGE's Asset Turnover Ratio HUGE's Dividend Growth
HUGE's Roe HUGE's Valuation Ratios HUGE's Financial Strength Ratios HUGE's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2025, within Healthcare Sector ROI

Date modified: 2026-06-23T19:22:26+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.